Figure 6
From: Bile metabolites as diagnostic biomarkers for perihilar cholangiocarcinoma
KEGG pathway enrichment analysis of metabolites. Select one of the important pathways shows (bile secretion pathway). The label denotes a potential important target of cholangiocarcinoma discovered in combination with literature review. C01921: Glycocholate; C02528: Chenodeoxycholic acid; C02538: Estrone sulfate; C05466: Glycochenodeoxycholate; C06999: Fexofenadine; C07014: Fluvastatin; C00026: 2-oxoglutaric acid; C01405: Aspirin; C05122: Taurocholic acid; C00695: Cholic acid; C03990: Lithocholic acid; C04483: Deoxycholic acid; C05465: Taurochenodeoxycholic acid; C16578: Morphine 6-beta-d-glucopyranosiduronide.
